Torcetrapib and atorvastatin [4] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 14, 2005, Pages 1527-1529

  Shear, Charles L ^a   Hirsch, Ronald L ^b   Green, Allan M ^c   Avorn, Jerry ^d  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b Signature Medical Associates   (United States)

^c Harvard Medical School ^*  (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CEFDINIR; CLARITHROMYCIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RITONAVIR; TORCETRAPIB; GENERIC DRUG; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE; QUINOLINE DERIVATIVE; PROTEINASE INHIBITOR;

CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; HUMAN; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; VALIDATION PROCESS; DRUG COMBINATION; DRUG LEGISLATION; NOTE; PATENT; UNITED STATES; DRUG INDUSTRY; ECONOMICS; BLOOD; CORONARY ARTERY ATHEROSCLEROSIS;

DRUG COMBINATIONS; DRUGS, GENERIC; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEGISLATION, DRUG; PATENTS; PYRROLES; QUINOLINES; UNITED STATES; DRUG COSTS; DRUG INDUSTRY; HIV PROTEASE INHIBITORS; RITONAVIR; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERIOSCLEROSIS;

EID: 25844475356     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc055277     Document Type: Letter

References (0)